Drug Manufacturers - General stocks, ranked

Live ranking of 10 Drug Manufacturers - General stocks by TickerMover Quant Score — a 0-100 composite of fundamentals, valuation, momentum, analyst signal, and macro regime. Click any ticker for the full breakdown.

These names score closely together — the group moves more as a block than as individual stories. These are descriptive measures of the group as it stands today, not a forecast and not a recommendation.

Ticker	Grade	Score	Bottom line
BMY Bristol-Myers Squibb Company	A	75	Top-tier setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
GILD Gilead Sciences, Inc.	A	73	Top-tier setup — +11% 30-day momentum, 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
PFE Pfizer Inc.	A	73	Top-tier setup — +12% 30-day momentum, 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
BIIB Biogen Inc.	A	72	Top-tier setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
AMGN Amgen Inc.	A	72	Top-tier setup — +12% 30-day momentum, 4/4 EPS beats, 23% net margin. Caveat: trades 10.2% above analyst mean target. Stock is trading above the analyst mean target ($388) — limited consensus headroom.
ABBV AbbVie Inc.	A	72	Top-tier setup — 3/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
MRK Merck & Co., Inc.	A	72	Top-tier setup — +14% 30-day momentum, 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
JNJ Johnson & Johnson	A	68	Top-tier setup — 3/4 EPS beats, 21% net margin. Momentum, fundamentals and macro indicators are aligned.
LLY Eli Lilly and Company	B	66	Solid setup — 48% revenue growth, 4/4 EPS beats, 34% net margin. Momentum, fundamentals and macro indicators are aligned.
AZN AstraZeneca PLC	C	53	Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.

Quant Scores update every 5 minutes during US market hours. Grades: A Top Tier · B Quality · C Average · D Below Avg · F Weak. (Quality descriptors, not buy/sell recommendations.)